Carin Louis
Carin Louis works as an advocate for the Dutch Federation of Cancer Patient Organizations (NFK), the umbrella organization of 21 cancer patient organizations. Her expertise lies in molecular diagnostics, early diagnosis, and access to innovative treatments in oncology.
In collaboration with various stakeholders, she is committed to optimizing the availability of molecular diagnostics in the Netherlands, with the goal of ensuring that every patient has equal access to the best possible (molecular) diagnostics and subsequent treatment. Additionally, Carin works with field partners to improve the early detection of cancer in high-risk groups.
Before joining NFK, Carin held various roles within the pharmaceutical industry, including in marketing, medical affairs, and patient engagement.